SEC Comment Letter 0000000000-24-008871 to NovoCure Ltd (NVCR) (CIK 0001645113) (NVCR)
NovoCure Ltd (NVCR) (CIK 0001645113)
Date: Aug. 2, 2024 · CIK: 0001645113 · Accession: 0000000000-24-008871
AI Filing Summary & Sentiment
Letter
August 2, 2024 Ashley Cordova Chief Financial Officer NovoCure Ltd 1550 Liberty Ridge Drive Wayne, PA United States Re:NovoCure Ltd Dear Ashley Cordova: Thank you for your response. We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
Show Raw Text
August 2, 2024
Ashley Cordova
Chief Financial Officer
NovoCure Ltd
1550 Liberty Ridge Drive
Wayne, PA
United States
Re:NovoCure Ltd
Dear Ashley Cordova:
Thank you for your response. We have completed our review of your filing. We remind
you that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services